vepdegestrant
Brand: VEPPANU
approved
Quick answer
vepdegestrant (VEPPANU), is a pharmaceutical active ingredient, with approved status in the US.
Key facts
- INN
- vepdegestrant
- Brand
- VEPPANU
- Route
- ORAL
- Formulation
- TABLET
Related news
Arvinas VEPPANU (Vepdegestrant) Receives FDA Approval as First PROTAC Drug for ESR1-Mutated Breast Cancer
Arvinas' VEPPANU becomes the first FDA-approved PROTAC drug for ESR1-mutated, ER+/HER2- advanced breast cancer, marking a breakthrough in protein degradation therapy.
Arvinas Receives FDA Approval for VEPPANU (Vepdegestrant), First PROTAC Drug for ESR1-Mutated Breast Cancer
Arvinas announces FDA approval of VEPPANU, the first PROTAC protein degrader for ESR1-mutated, ER+/HER2- advanced breast cancer treatment.
Frequently asked questions
What is vepdegestrant?
vepdegestrant (VEPPANU), is a pharmaceutical active ingredient, with approved status in the US.
What is the brand name for vepdegestrant?
VEPPANU is a marketed brand name for vepdegestrant. Check FDA Drugs@FDA for the current US label holder.